title: Human papilloma virus vaccines and their role in cancer prevention.
abstract: The introduction of the human papilloma virus (HPV) vaccine is the single most important advance in the prevention of cervical cancer since the introduction of cervical cytology half a century ago. Vaccination should ideally occur prior to a female's first sexual experience. This article suggests that the HPV vaccine should be publicly funded in New Zealand.
authors.affiliation: Gynaecological Oncology Service, National Women's Hospital, Private Bag 92 189, Auckland. MBarrios@adhb.govt.nz
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Jones
authors.forename: Edward P
authors.initials: EP
authors.lastname: Coughlan
authors.forename: J Stewart
authors.initials: JS
authors.lastname: Reid
authors.forename: Peter
authors.initials: P
authors.lastname: Sykes
authors.forename: Peter D
authors.initials: PD
authors.lastname: Watson
authors.forename: Catherine
authors.initials: C
authors.lastname: Cook
mesh_terms: D015984:Causality; D015897:Comorbidity; D003218:Condylomata Acuminata / Q000453:epidemiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000639:trends; D015994:Incidence; D008297:Male; D009520:New Zealand / Q000453:epidemiology; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D015995:Prevalence; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D053918:Papillomavirus Vaccines